Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prayon is a Belgian-headquartered global leader in phosphorus chemistry specializing in the manufacture of high-quality phosphate and fluorine solutions used across food & beverage industries as well as technical applications including pharmaceuticals. The company produces ultrapure phosphoric acid grades under brands such as Interbex Pharma and Superbex Pharma—primarily used as cleaning agents or functional excipients within pharmaceutical manufacturing—and also offers specialized hypophosphorous acid products. With over a century of expertise and approximately 1,500 employees worldwide across sites in Belgium, France, Switzerland and the US plus R&D/testing facilities elsewhere,[1][2][3][4] Prayon serves customers globally through its extensive product portfolio but does not itself develop therapeutics or maintain a drug development pipeline. Its main shareholders are OCP Group—the world’s largest producer of phosphoric acid—and Wallonie Entreprendre.[2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prayon.